Actively Recruiting

Age: 18Years +
All Genders
ID06335251

Radiotherapy Treatments for Neoplasms of the Limbs

Led by European Institute of Oncology · Updated on 2025-08-28

3000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are collecting data from patients treated with radiotherapy for tumors located in the upper or lower limbs. This observational study includes patients with various primary tumors or metastases affecting these areas. The aim is to better understand radiotherapy treatment characteristics, tolerance, and effectiveness to help guide future treatment strategies for these types of cancers. Participants receive radiotherapy for different purposes such as curative, palliative, neo-adjuvant, or adjuvant treatment targeting bone, soft tissue, cardio-circulatory system, lymphatic system, nervous system, skin tumors, or secondary metastases in limbs. Data is gathered from patients receiving these treatments as part of their standard cancer care. During the study, researchers collect clinical and treatment-related data to evaluate outcomes like overall survival and disease-free survival over five years. This information will contribute to scientific knowledge and help develop better treatment protocols. The total participation time varies as data is collected during routine care and follow-up periods.

CONDITIONS

Brief Title

Radiotherapy Treatments for Neoplasms of the Limbs

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients treated with radiotherapy for curative, palliative, neo-adjuvant, or adjuvant purposes in the upper and lower limbs for primary bone tumors, primary soft tissue tumors, tumors of the cardio-circulatory, lymphatic, nervous system, skin, or secondary metastases in those areas
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Radiotherapy in areas other than the limbs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 5 years

Participants who undergo routine radiotherapy treatments to the limbs are observed to collect data on treatment tolerance and effectiveness.

Visits as part of routine care and follow-up

Trial Site Locations

Total: 1 location

1

European Institute of Oncology

Milan, Italy

Actively Recruiting

Loading map...

Research Team

B

Barbara Alicja Jereczek

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Phase III Randomized Trial Comparing Stereotactic Body Rad...

Bone Metastases

Actively Recruiting

1 location

An Electronic Health Record (EHR)-Based Comprehensive Bone a...

Neoplasms, Connective and Soft Tissue

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here